Meet the Director R & R
Dr Monica Hemben Eimunjeze currently serves as the Director of Registration & Regulatory Affairs for the Agency.
She previously served as the Technical Assistant to the Director General of NAFDAC and as the Director, Drug Evaluation and Research.
Dr Eimunjeze has coordinated several national and international programmes to support strengthening regulatory capacity within the Agency and worked on several projects to institute regulatory reform.
She has represented the Agency and made presentations at several fora highlighting the Agency’s activities and achievements.
She graduated from the Ahmadu Bello University Zaria with a Bachelor of Pharmacy in 1986 and went on to obtain a Doctor of Pharmacy (Pharm D) from Mercer University, Atlanta Georgia and a Master of Science (MSc) in Biotechnology, Innovation and Regulatory Science from Purdue University.
Dr Eimunjeze has a varied experience in the pharmaceutical sector spanning different areas of practice. Her industrial exposure with GlaxoSmithKline from 1989 to 1996 saw her holding several positions including Medical Representative, Quality Manager and Regulatory Affairs Manager.
She has attended several courses, workshops and conferences in Quality Management Systems (QMS), Clinical Trial Regulation, Good Manufacturing Practice (GMP), Biotechnology and Regulatory Affairs.
Dr Eimunjeze currently serves as a member of the Expert Scientific Advisory Committee (ESAC) Medicines for Malaria Ventures (MMV). She is a member of the Task Team for the creation of the African Medicines Agency (AMA) and is NAFDAC representative at the United States Pharmacopoeia as Convention observer. She serves as Focal person for the Economic Community of West African States Medicines Regulatory Harmonisation (ECOWAS MRH) for NAFDAC and is the Focal person for Dossier Assessment in the Collaborative Procedure for Registration of WHO–Prequalified Pharmaceutical Products.
Dr Eimunjeze is a Fellow of the Pharmaceutical Society of Nigeria and is married with children.